Sign in
4

Changes in Ownership

ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001209191-19-011829

Chief Operating Officer sold 68,750 shares at an average $17.86 ($1,227,988)

  • Chief Operating Officer acquired 42,500 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
GIVEN BRUCE D Chief Operating Officer 2019-02-15 Sale −26,250 $17.67 $463,838 644,606 D
GIVEN BRUCE D Chief Operating Officer 2019-02-19 Option exercise +42,500 $2.01 $85,425 687,106 D
GIVEN BRUCE D Chief Operating Officer 2019-02-19 Sale −42,500 $17.98 $764,150 644,606 D
Derivatives
GIVEN BRUCE D Chief Operating Officer 2019-02-19 Option exercise · Stock Option (right to buy) −42,500 435,000 D
Open-market sales · 68,750 sh · avg $17.86 · $1,227,988
Loading xslF345X03/doc4.xml…